Accomplishments in 2007 in biologic markers for gastrointestinal cancers.
OverviewPrognostic or Predictive Factors K-ras and Ligands of EGFRCirculating Tumor CellsArray Signatures as Prognostic/Predictive Markers18q and MSI as Prognostic MarkersUse of Thymidylate Synthase To Assign ChemotherapyAccomplishments (or Lack of Accomplishments) Therapy Incorporation of Targeted Therapies in Colon Cancer TreatmentIncorporation of Targeted Therapies in Pancreatic Cancer TreatmentUGT1A1*28 Polymorphism and Irinotecan ToxicityBasic Science Targeting VEGFIdentification of VEGF-Independent PathwaysTargeting EGFRTargeting Other PathwaysFuture Directions Comments on ResearchFuture Challenges.
Lenz
Heinz-Josef
HJ
Division of Medical Oncology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA.
Johnston
Patrick
P